magic bullet. Modern medicine has found ways to send signals to the body's DNA to alter a structure that is either malfunctioning or failing to function at maximum potential. Hundreds of these so-called magic bullets have been designed; some by other companies. The problem, to date, has been finding a way to get the bullet quickly, efficiently and in sufficient quantity to the gene in need of change. CytoGenix has solved this important problem with their patented, proprietary technology. It is this technology that may enable CYGX to capture a significant share of a massive market in the USA and the world
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.